-
公开(公告)号:US20240293535A1
公开(公告)日:2024-09-05
申请号:US18262033
申请日:2022-01-18
Applicant: GlaxoSmithKline Biologicals SA
Inventor: Johann MOLS , Marie TOUSSAINT
IPC: A61K39/245 , A61P31/22 , C07K14/005
CPC classification number: A61K39/245 , A61P31/22 , C07K14/005 , C12N2710/16622 , C12N2710/16634
Abstract: The present invention relates to a HSV2 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV1 in a subject. Also provided is a HSV1 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV2 when administered to a subject.
-
公开(公告)号:US20240091345A1
公开(公告)日:2024-03-21
申请号:US18262073
申请日:2022-01-18
Applicant: GlaxoSmithKline Biologicals SA
Inventor: Johann MOLS , Marie TOUSSAINT
IPC: A61K39/245 , A61P31/22
CPC classification number: A61K39/245 , A61P31/22 , A61K2039/53
Abstract: The present invention relates to a nucleic acid encoding a HSV2 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV1 in a subject. Also provided is a nucleic acid encoding a HSV1 Fc receptor or immunogenic fragment or variant thereof for use in generating a cross reactive immune response against HSV2 when administered to a subject.
-
公开(公告)号:US20220273789A1
公开(公告)日:2022-09-01
申请号:US17627998
申请日:2020-07-20
Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
Inventor: Normand BLAIS , Cindy CASTADO , Johann MOLS , Lionel SACCONNAY , Marie TOUSSAINT , Newton Muchugu WAHOME , Giulietta MARUGGI
IPC: A61K39/245 , C07K14/005 , A61P31/22 , A61P37/04
Abstract: The present invention relates to viral Fc receptor or immunogenic fragments thereof for treating a viral infection in a subject and, in particular, a herpes vims infection. The present invention also relates to a heterodimer comprising or consisting of an Fc receptor from a HSV vims or an immunogenic fragment thereof and a binding partner from said HSV vims or a fragment thereof, for use in therapy.
-
-